Research Projects & Grants

Internal

• Evaluation of cumulative doses of intravenous Lorazepam for the management of Status Epilepticus in the Emergency department, Role: PI, LLU Dept. of Pharmacy Practice, (10/2023) Status: Approved
• Comparison of epinephrine versus norepinephrine on post cardiac arrest outcomes, Role: PI, LLU Dept. of Pharmacy Practice, (01/2023) Status: Approved
• Comparison between Methylprednisolone vs. Dexamethasone for the treatment of hospitalized COVID-19 patients, Role: PI, LLU Dept. of Pharmacy Practice, (10/2021) Status: Approved
• Evaluation of Heparin Induced Thrombocytopenia & Thrombosis (HITT) in COVID-19 (Case series), Role: PI, LLU Dept. of Pharmacy Practice, (05/2021) Status: Approved
• Intravenous Lidocaine Infusion for Pain in Critically Ill Patients, Role: Investigator, LLU Dept. of Pharmacy Practice, (12/2020) Status: Approved
• The effectiveness of the vasopressor Angiotensin-II in septic shock or vasodilatory shock patients, Role: Investigator, LLU Dept. of Medicine, (04/2020 - 03/2021) Status: Completed
• Enoxaparin in Special Population: Assessing Appropriateness of Standard Treatment Dose in Obese Patient, Role: PI, LLU Dept. of Pharmacy Practice, (10/2019) Status: Approved
• Use of acetylcysteine in non-acetaminophen induced acute liver failure and its effect on ALT, total bilirubin and INR, Role: PI, LLU Dept. of Pharmacy Practice, (04/2016 - 04/2017) Status: Completed
• Retrospective evaluation of the 4T's score for development and evaluation of Heparin-Induced Thrombocytopenia (HIT) recognition guideline/protocol, Role: Investigator, LLU Dept. of Pharmacotherapy and Outcomes Sciences, (11/2012 - 11/2013) Status: Completed
• High dose Amikacin for empiric therapy in critically ill patients with septic shock, Role: PI, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved